These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20360530)

  • 1. The evidence-based approach in bringing new orthopaedic devices to market.
    Schemitsch EH; Bhandari M; Boden SD; Bourne RB; Bozic KJ; Jacobs JJ; Zdero R
    J Bone Joint Surg Am; 2010 Apr; 92(4):1030-7. PubMed ID: 20360530
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing landscape of product development and randomized trials.
    Stengel D
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():85-91. PubMed ID: 22810455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Market approval processes for new types of spinal devices: challenges and recommendations for improvement.
    Bisschop A; van Tulder MW
    Eur Spine J; 2016 Sep; 25(9):2993-3003. PubMed ID: 27235154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of orthopaedic device registries in improving patient outcomes.
    Maloney WJ
    J Bone Joint Surg Am; 2011 Dec; 93(24):2241. PubMed ID: 22258768
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation Between Conditional Approval and Customized Bone Implant Devices.
    Guo XL; Liu B; Lu Z
    Orthop Surg; 2019 Feb; 11(1):10-14. PubMed ID: 30834707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trials investigating the therapeutic benefit of medical devices in orthopaedics and trauma surgery: practice examples plus commentary].
    Kirschner S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):342-6; discussion 346. PubMed ID: 22818155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based medicine and drug-eluting stents.
    O'Dwyer J
    Med Device Technol; 2004 May; 15(4):34-7. PubMed ID: 15303564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory approval process for medical device].
    Tabayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):1. PubMed ID: 15696689
    [No Abstract]   [Full Text] [Related]  

  • 9. The natural history of new orthopaedic devices.
    Bhattacharyya T; Blyler C; Shenaq D
    Clin Orthop Relat Res; 2006 Oct; 451():263-6. PubMed ID: 16906061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Oct; 69(191):59132-4. PubMed ID: 15460583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on orthopaedic and casualty surgery in Germany].
    Niethard FU; Weise K
    Z Orthop Unfall; 2010 Mar; 148(2):143-4. PubMed ID: 20376756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Benefit assessment of medical devices].
    Zens Y; Fujita-Rohwerder N; Windeler J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Mar; 58(3):240-7. PubMed ID: 25566843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stakeholder approach: a new perspective on developing and marketing clinical trials.
    Droms CM; Ferguson M; Giuliano K
    Health Mark Q; 2014; 31(1):1-12. PubMed ID: 24617719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trials with medical devices: lack of quality illustrated for faecal incontinence].
    Vonthein R; Hemmelmann C; König IR; Schwandner T; Bruch HP; Ziegler A
    Zentralbl Chir; 2012 Aug; 137(4):380-4. PubMed ID: 21739411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of pediatric orthopaedic devices: important issues for the future.
    Sheha ED; Hammouri Q; Snyder BD; Campbell RM; Vitale MG;
    J Bone Joint Surg Am; 2014 Feb; 96(3):e21. PubMed ID: 24500593
    [No Abstract]   [Full Text] [Related]  

  • 16. Off-Label Use in Orthopaedic Surgery.
    Taylor BC; Triplet JJ; El-Sabawi T
    J Am Acad Orthop Surg; 2019 Sep; 27(17):e767-e774. PubMed ID: 30550397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based use of cardiac procedures and devices.
    Hlatky MA
    N Engl J Med; 2004 May; 350(21):2126-8. PubMed ID: 15152058
    [No Abstract]   [Full Text] [Related]  

  • 18. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    Geraghty PJ; Matsumura JS; Conte MS
    J Vasc Surg; 2009 Dec; 50(6):1459-61. PubMed ID: 19897333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Marketing approval and market surveillance of medical devices in Germany: Where does policy integration take place?].
    Lang A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):320-4. PubMed ID: 25066351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.